Dapagliflozin Tablets
Pre-Solicitation Posted
- Solicitation number
- SPE2D2-26-R-0018
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support is planning to issue a solicitation for a national requirements contract for Dapagliflozin Tablets with a projected release in October 2026; this is an unrestricted and fully competitive acquisition with no set-aside.
The contract will be firm-fixed price, requirements type with a one-year base and four one-year options. Products covered are Dapagliflozin 5 MG tablets in 30 and 90 count bottles and 10 MG in 30 and 90 count bottles. The resulting contract will establish a national supply source under FAR 52.216-21 to serve the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. Annual usage estimates will appear in the Schedule of Supplies section of the solicitation.
This is a commercial item procurement conducted under FAR part 12. The solicitation will post to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov. DLA reserves the right to issue the solicitation before or after the October 2026 projected date. Interested parties should contact Ryan Guarnere (445-737-1729, Ryan.Guarnere@dla.mil) for questions and should set up automated notifications through SAM.gov to track pre-solicitation and solicitation changes.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Dapagliflozin Tablets. Procurement details follow.
Dapagliflozin 5 MG tablets in 30 and 90 count bottles and 10 MG in 30 and 90 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.gov at https://sam.gov/. Interested parties should contact Ryan Guarnere (445-737-1729) (Ryan.Guarnere@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is October 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Febuxostat Tablets | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Prednisolone 1% Ophthalmic Solution | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity